Detalhe da pesquisa
1.
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes.
BJOG
; 129(12): 1970-1980, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781768
2.
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.
J Med Genet
; 53(7): 472-80, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993268
3.
Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium.
Mol Cytogenet
; 17(1): 9, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627791
4.
Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes.
Front Genet
; 13: 975987, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36105088
5.
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.
J Natl Cancer Inst
; 107(1): 379, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25435541
6.
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
J Natl Cancer Inst
; 107(1): 380, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25435542